Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection

Ophthalmology

Volumn 119, Issue 7, 2012, Pages 1420-1424

  Milder, Eugene ^a   Vander, James ^a   Shah, Chirag ^a   Garg, Sunir ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; EYE DROPS; GATIFLOXACIN; MOXIFLOXACIN; OFLOXACIN; POLYMYXIN B; POVIDONE IODINE; RANIBIZUMAB; TRIMETHOPRIM; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL FLORA; BACTERIUM COLONY; CASE CONTROL STUDY; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONJUNCTIVA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG SENSITIVITY; EXUDATIVE MACULAR DEGENERATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

EID: 84863329970     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.01.016     Document Type: Article

References (27)

1. D.R. Fintak, G.K. Shah, K.J. Blinder Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab Retina 28 2008 1395 1399
2. C.P. Shah, S.J. Garg, J.F. Vander Post-Injection Endophthalmitis (PIE) Study Team Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents Ophthalmology 118 2011 2028 2034
3. R.D. Jager, L.P. Aiello, S.C. Patel, E.T. Cunningham Jr Risks of intravitreous injection: a comprehensive review Retina 24 2004 676 698
4. S. Pilli, A. Kotsolis, R.F. Spaide Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting Am J Ophthalmol 145 2008 879 882
5. A.R. Bhavsar, J.M. Googe Jr, C.R. Stockdale Diabetic Retinopathy Clinical Research Network Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the Diabetic Retinopathy Clinical Research Network laser-ranibizumab-triamcinolone clinical trials Arch Ophthalmol 127 2009 1581 1583
6. S.J. Kim, H.S. Toma Ophthalmic antibiotics and antimicrobial resistance: a randomized, controlled study of patients undergoing intravitreal injections Ophthalmology 118 2011 1358 1363
7. P.B. Knecht, S. Michels, V. Sturm Tunnelled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort Retina 29 2009 1175 1181
8. E.B. Rodrigues, A. Grumann Jr, F.M. Penha Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection J Ocul Pharmacol Ther 27 2011 197 203
9. D. Maurice Review: practical issues in intravitreal drug delivery J Ocul Pharmacol Ther 17 2001 393 401
10. D.F. Chang, R. Braga-Mele, N. Mamalis ASCRS Cataract Clinical Committee Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey J Cataract Refract Surg 33 2007 1801 1805
11. S.M. Hariprasad, K.J. Blinder, G.K. Shah Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous Arch Ophthalmol 123 2005 39 44
12. M. Moshirfar, V. Feiz, A.T. Vitale Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series Ophthalmology 114 2007 686 691
13. V.A. Deramo, J.C. Lai, D.M. Fastenberg, I.J. Udell Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin Am J Ophthalmol 142 2006 721 725
14. D.M. Brown, M. Michels, P.K. Kaiser ANCHOR Study Group Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study Ophthalmology 116 2009 57 65
15. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
16. R.E. Fintelmann, E.N. Hoskins, T.M. Lietman Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures Arch Ophthalmol 129 2011 399 402
17. S.H. Park, J.A. Lim, J.S. Choi The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics Cornea 28 2009 68 72
18. C.N. Ta, R.T. Chang, K. Singh Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery Ophthalmology 110 2003 1946 1951
19. S.J. Kim, H.S. Toma, N.K. Midha Antibiotic Resistance of Conjunctiva and Nasopharynx Evaluation Study: a prospective study of patients undergoing intravitreal injections Ophthalmology 117 2010 2372 2378
20. J.L. Chung, K.Y. Seo, D.E. Yong Antibiotic susceptibility of conjunctival bacterial isolates from refractive surgery patients Ophthalmology 116 2009 1067 1074
21. J.M. Moss, S.R. Sanislo, C.N. Ta Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections Ophthalmology 117 2010 2141 2145
22. D.C. Hooper Emerging mechanisms of fluoroquinolone resistance Emerg Infect Dis 7 2001 337 341
23. D. Miller, P.M. Flynn, I.U. Scott In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates Arch Ophthalmol 124 2006 479 483
24. P.A. Asbell, K.A. Colby, S. Deng Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates Am J Ophthalmol 145 2008 951 958
25. F.W. Price Jr, K. Dobbins, W. Zeh Penetration of topically administered ofloxacin and trimethoprim into aqueous humor J Ocul Pharmacol Ther 18 2002 445 453
26. S.M. Araújo, T.C. Mourão, J.L. Oliveira Antimicrobial resistance of uropathogens in women with acute uncomplicated cystitis from primary care settings Int Urol Nephrol 43 2011 461 466
27. K. Gupta, D. Scholes, W.E. Stamm Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women JAMA 281 1999 736 738